IntraCellular Seeks To Raise $400M Via Equity To Fund Commercialization Of Schizophrenia MedBenzinga • 01/04/22
Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in AdultsGlobeNewsWire • 12/20/21
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/21
Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and WebcastGlobeNewsWire • 11/02/21
Intra-Cellular Therapies to Host a Virtual Event to Feature Highlights of Several of its Development ProgramsGlobeNewsWire • 10/08/21
Intra-Cellular says clinical study shows its schizophrenia drug helps patients with bipolar disorderMarket Watch • 09/27/21
Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of PsychiatryGlobeNewsWire • 09/27/21
Intra-Cellular Therapies Announces Publications Highlighting Beneficial Effects of Phosphodiesterase Type I Inhibition with Lenrispodun (ITI-214) on Cardiovascular Function in Patients with Heart Failure and in Models of Accelerated AgingGlobeNewsWire • 09/20/21
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/09/21
Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/09/21
Will Intra-Cellular Therapies (ITCI) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 08/02/21
CAPLYTA® (lumateperone) Schizophrenia Safety and Tolerability Profile Published in the Journal, International Clinical PsychopharmacologyGlobeNewsWire • 06/07/21
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising InvestmentSeeking Alpha • 06/02/21
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21